SCHEMBL19637502

SCHEMBL19637502

C=CCOC(=O)Nc1ccc2cnn(C(=O)c3cc(NC(=O)c4cc(NC(=O)c5nc(N)cn5C)cn4C)cn3C)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERBB2 P04626 6/20 0.42
▸ FGFR1 P11362 1/20 0.35
▸ FGFR4 P22455 1/20 0.35
▸ AGPAT2 O15120 1/20 0.33
▸ HTR1A P08908 1/20 0.31
▸ HTR1B P28222 1/20 0.31
▸ HTR1F P30939 1/20 0.31
▸ HRAS P01112 4/20 0.31
▸ ESR1 P03372 4/20 0.31
▸ ESR2 Q92731 4/20 0.31
▸ TOP1 P11387 1/20 0.31
▸ HDAC1 Q13547 2/20 0.31
▸ HDAC2 Q92769 2/20 0.31
▸ HDAC8 Q9BY41 2/20 0.31
▸ P2RY12 Q9H244 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637500 0.87 ERBB2 (0.43) ERBB2FGFR1FGFR4HDAC1HDAC2
SCHEMBL19614875 0.85 FGFR1 (0.39) ERBB2FGFR1FGFR4AGPAT2HTR1A
SCHEMBL19633096 0.84 FGFR1 (0.37) ERBB2FGFR1FGFR4AGPAT2HDAC8
SCHEMBL19633090 0.84 ERBB2 (0.41) ERBB2AGPAT2HRASESR1ESR2
Hydrochloric Acid SCHEMBL30464341 0.83 ERBB2 (0.39) ERBB2AGPAT2HRASESR1ESR2
Hydrochloric Acid SCHEMBL19614885 0.83 ERBB2 (0.39) ERBB2AGPAT2HRASESR1ESR2
Hydrochloric Acid SCHEMBL30464359 0.83 ERBB2 (0.41) ERBB2AGPAT2HRASESR1ESR2
SCHEMBL19633039 0.82 ERBB2 (0.40) ERBB2AGPAT2HRASESR1ESR2
Hydrochloric Acid SCHEMBL30464360 0.81 ERBB2 (0.40) ERBB2AGPAT2HRASESR1ESR2
SCHEMBL19636936 0.81 ERBB2 (0.40) ERBB2AGPAT2HRASESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof MERSANA THERAPEUTICS, INC. (US) 2020-05-26 — — US disclosed
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2019-03-07 — — US disclosed
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MERSANA THERAPEUTICS, INC. 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333442-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B ERBB2 65/4885FGFR1 1664/4885FGFR4 1022/4885
US-20190070194-A1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF CD79B, CLTB, FCGR3B ERBB2 65/4885FGFR1 1664/4885FGFR4 1022/4885
US-10660901-B2 Pyrrolobenzodiazepines and conjugates thereof CD79B, CLTB, FCGR3B ERBB2 65/4885FGFR1 1664/4885FGFR4 1022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback